Latest Articles

Technology Networks invited Dr. Heifets, assistant professor at the Stanford School of Medicine, to an Ask Me Anything session to answer your questions about psychedelics.

Technology Networks invited chief editor at Nature Biotechnology, Barbara Cheifet, to an Ask Me Anything session to answer questions about the biggest challenges in scientific publishing and how to get work published in high-ranking journals.

Using data provided by Intercontinental Exchange, My Green Lab has produced a report providing key insights into the current state of the sector’s carbon emissions. James Connelly highlights some of the key findings and their significance.

The COVID-19 global pandemic has left in its wake a baffling array of symptoms, affecting many survivors for months after the virus has run its course. This article explores the current state of long COVID research.

Chronic sleep disruption (CSD) has been shown to promote pain. Now, a team of scientists have shed light on some of the brain regions and signaling molecules that may be responsible, offering potential avenues for therapeutic investigation.

Technology Networks invited Dr. Nigel Jamieson, clinical senior lecturer and honorary hepato-pancreato-biliary surgeon at Glasgow Royal Infirmary, to an Ask Me Anything session to answer your questions about spatial biology.

Martin Farley, sustainable research adviser at UCL and director of Green Lab Associates, was invited to Technology Networks’ Ask Me Anything session to answer your questions about the future of sustainability in research and laboratory practices.

Hello and welcome to the Pulse, the monthly psychedelics industry roundup from Technology Networks and Analytical Cannabis. Here, we’ll highlight some of the most significant psychedelic industry news from the past month, including important announcements, pre-clinical work and the latest from groundbreaking psychedelic clinical trials.

Bayesian statistics has emerged as a powerful methodology for making decisions from data in the applied sciences. Bayesian brings a new way of thinking to statistics, in how it deals with probability, uncertainty and drawing inferences from an analysis.

The gene therapy landscape is dynamic and constantly shifting. In this article, we will review major advances in disease modification for illnesses that presently still lack effective treatments, as well as some challenges and approaches to overcome them.